Asia-Pacific IVF Services Market: Global Opportunity Analysis and Industry Forecast (2018-2028) - ResearchAndMarkets.com

DUBLIN--()--The "Asia-Pacific IVF Services Market by Cycle Type and End User - Global Opportunity Analysis and Industry Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering.

The market generated $3,734 million in 2017 and is projected to reach $13,669 million by 2028, growing at a CAGR of 12.4% from 2018 to 2028.

Increase in infertility rate, rise in trend of delayed pregnancies, surge in IVF success rate, and growth in disposable income in Asia-Pacific region drive the growth of the IVF services market. However, the market growth is restricted by complications associated with IVF treatment, and low awareness level for IVF in some under developed regions.

Based on cycle-type, the fresh cycle (non-donor) segment is major revenue contributor and is expected to dominate the market during the forecast period.

Depending on end user, the Asia-Pacific IVF services market is dominated by the fertility clinics segment and is estimated to continue this trend during the forecast period, due to low cost of treatment and increase in number of fertility clinics.

Key Findings

  • Fresh IVF cycle (non-donor) segment is expected to grow at a significant CAGR of 12.9% (in terms of value) from 2018 to 2028
  • Japan generated the highest revenue in the Asia-Pacific IVF services market in 2017 accounting for nearly half of the market share in 2017
  • Japan witnessed the highest number of IVF treatments accounting for nearly two-fifths of the total cycles in 2017 and is expected to remain so throughout the forecast period
  • India is expected to register the highest CAGR of 15.3% (in terms of value) throughout the forecast period
Companies Featured
  • Apollo Hospitals Dhaka
  • Bahosi Fertility Centre
  • Bangkok IVF center
  • Bloom Fertility and Healthcare
  • Bloom Fertility Center
  • Bourn Hall Fertility Center
  • Bumrungrad International Hospital
  • CHA Fertility Center
  • Chennai Fertility Center
  • Cloudnine Fertility
  • Damai Service Hospital
  • Fertility First
  • Genea Oxford Fertility Limited
  • IHH Healthcare Berhad
  • IVF NAMBA Clinic
  • IVF Van Hanh
  • KL Fertility & Gynecology Centre
  • Lanka Hospitals
  • Lotus Fertility Clinic
  • Manipal Fertility
  • Maria Fertility Hospital
  • MEHR IVF Clinic
  • Morula IVF
  • National University Hospital
  • Oak Medical Group/Oak Clinic
  • Raffles Medical Group
  • Repromed
  • Shanghai
  • United Family Hospital
  • Southend Fertility and IVF
  • Thomson Medical Pte. Ltd.
  • TMC Fertility Centre
  • Tu Du Hospital
  • Virtus Health
  • and many more...

For more information about this report visit https://www.researchandmarkets.com/research/q22hzl/asiapacific_ivf?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health